News in Brief
Health - 08:01
Novartis Kisqali receives the highest rating of any CDK4/6 inhibitor on the ESMO Magnitude of Clinical Benefit Scale
Novartis Kisqali receives the highest rating of any CDK4/6 inhibitor on the ESMO Magnitude of Clinical Benefit Scale
Pharmacology - Sep 19
Novartis reports late-breaking data from Phase III COMBI-i trial of spartalizumab (PDR001) with Tafinlar and Mekinist in advanced melanoma
Novartis reports late-breaking data from Phase III COMBI-i trial of spartalizumab (PDR001) with Tafinlar and Mekinist in advanced melanoma
wire - news in brief
Category
Results 151 - 200 of 458.
New data from phase IIIb study reinforces safety profile of Roche’s Hemlibra in people with haemophilia A
Second interim analysis of the STASEY study, including data from 193 patients, consistent with results from phase III HAVEN studies, with no new safety signals identified 1,2,3 STASEY is the largest
Second interim analysis of the STASEY study, including data from 193 patients, consistent with results from phase III HAVEN studies, with no new safety signals identified 1,2,3 STASEY is the largest
We continue our journey to discover the USI Faculty of Biomedical Sciences with Marta Fadda, post-doctoral researcher and lecturer, with whom we talk about social and cultural patterns, medical ethic
In a project under Horizon 2020, researchers from seven European organizations will examine how the vision of visually impaired people can be restored using electrical stimulation of the brain.
Celeste Carruth originally planned to be a musician. Now she is a physicist at ETH working to develop a new technique for controlling ions.
Maryna Viazovska, who holds the Chair of Number Theory at EPFL, has resolved the problem of sphere packing in 8 and 24 dimensions.
Acceptance and Commitment Therapy (ACT) is still a relatively young approach from behavioral therapy, but has already proven itself in the treatment of a wide range of mental disorders.
An EPFL laboratory has developed DataShare Network, a decentralized search engine paired with a secure messaging system that allows investigative journalists to exchange information securely and anonymously.
There is less fear of coronavirus since the end of the lockdown, but 40% of the population still feels more stressed than before the pandemic began.
100%SwissDEM: everyone counts
The 100%SwissDEM awareness-raising campaign, which is aimed at giving voice to the elderly to encourage the discussion on research and issues related to the health and well-being of the population aged 65 and over, has reached the halfway point.
The 100%SwissDEM awareness-raising campaign, which is aimed at giving voice to the elderly to encourage the discussion on research and issues related to the health and well-being of the population aged 65 and over, has reached the halfway point.
Agroscope Publishes Study on Environmental Impacts of Drinking-Water Initiative
In an in-depth study, Agroscope analysed the possible environmental impacts of implementing the Drinking-Water Initiative. The life-cycle assessment shows that pesticide and nutrient pollution of Swiss water bodies and groundwater could be reduced. In addition, inland biodiversity could be improved slightly.
In an in-depth study, Agroscope analysed the possible environmental impacts of implementing the Drinking-Water Initiative. The life-cycle assessment shows that pesticide and nutrient pollution of Swiss water bodies and groundwater could be reduced. In addition, inland biodiversity could be improved slightly.
Influx from the SP helps the Greens to win elections
Due to widespread concerns about the climate, the environmental parties made significant gains in the 2019 federal elections, especially among young voters.
Due to widespread concerns about the climate, the environmental parties made significant gains in the 2019 federal elections, especially among young voters.
A long-term study on the effects of the coronavirus pandemic is being carried out in the cantons of Basel-Stadt and Basel-Landschaft.
The technology pioneered by the ETH spin-off incon.ai allows blocks to be positioned with pinpoint accuracy, creating structures with aesthetic designs and augmented acoustics. Shadow plays, wavelike patterns or acoustic effects: bricks can be placed at special angles to create aesthetic architectural designs.
EPFL's first-year architecture students usually have the chance to build full-scale versions of their designs.
Swissuniversities and Springer Nature sign a new Open Access agreement
Swissuniversities has adopted a new transformative Open Access agreement with Springer Nature.
Swissuniversities has adopted a new transformative Open Access agreement with Springer Nature.
Ethics and AI: an unethical optimization principle
EPFL professor Anthony Davison and co-authors provide a mathematical basis for concerns about ethical implications of AI. Artificial intelligence (AI) is increasingly deployed around us and may have large potential benefits. But there are growing concerns about the unethical use of AI. Professor Anthony Davison, who holds the Chair of Statistics at EPFL, and colleagues in the UK, have tackled these questions from a mathematical point of view, focusing on commercial AI that seek to maximize profits.
EPFL professor Anthony Davison and co-authors provide a mathematical basis for concerns about ethical implications of AI. Artificial intelligence (AI) is increasingly deployed around us and may have large potential benefits. But there are growing concerns about the unethical use of AI. Professor Anthony Davison, who holds the Chair of Statistics at EPFL, and colleagues in the UK, have tackled these questions from a mathematical point of view, focusing on commercial AI that seek to maximize profits.
Advances in next-generation-sequencing technology that allow researchers to look at billions of pieces of genetic information are changing the way a disease is diagnosed. Correct identification of changes in the human genetic code responsible for rare metabolic disorders provides scientists and physicians with fact-based guidelines for the treatment.
Many scientists are currently undertaking work on the Sars-CoV-2 virus. But hundreds of projects supported by the SNSF are already contributing to finding answers to the current health crisis. In Switzerland and around the world, the novel coronavirus has become a priority for scientific research. Projects supported by the Swiss National Science Foundation (SNSF) are no exception.
A healthcare solution born in an ETH student workshop has now entered mass production: the helpfulETH initiative is supporting hospitals during the coronavirus crisis by producing special face shields.
Novartis Cosentyx gains positive CHMP opinion for pediatric psoriasis, reinforcing established efficacy and safety profile
EMA CHMP positive opinion paves way for Cosentyx to become a first-line systemic treatment in pediatric psoriasis CHMP opinion based on two Phase III studies showing Cosentyx provides fast and stro
EMA CHMP positive opinion paves way for Cosentyx to become a first-line systemic treatment in pediatric psoriasis CHMP opinion based on two Phase III studies showing Cosentyx provides fast and stro
Novartis receives positive CHMP opinion for new Xolair indication to treat severe chronic rhinosinusitis with nasal polyps
If approved, Xolair (omalizumab) will provide patients who have severe chronic rhinosinusitis with nasal polyps, not adequately controlled by intranasal corticosteroids, with the first anti-immunoglo
If approved, Xolair (omalizumab) will provide patients who have severe chronic rhinosinusitis with nasal polyps, not adequately controlled by intranasal corticosteroids, with the first anti-immunoglo
Bestnote für zwei Tourismusprogramme
Die Welttourismusorganisation zertifiziert zwei Studiengänge an der Fachhochschule Graubünden mit Bestnoten 26. Juni 2020 The University of Applied Sciences of the Grisons was awarded the top grade by the World Tourism Organization UNWTO for two of its study programmes.
Die Welttourismusorganisation zertifiziert zwei Studiengänge an der Fachhochschule Graubünden mit Bestnoten 26. Juni 2020 The University of Applied Sciences of the Grisons was awarded the top grade by the World Tourism Organization UNWTO for two of its study programmes.
Novartis Resolves Legacy FCPA Investigations
Basel, June 25, 2020 - Novartis has reached settlements with the US Department of Justice (DOJ) and the US Securities and Exchange Commission (SEC) resolving all Foreign Corrupt Practices Act (FCPA) investigations into historical conduct by the Company and its subsidiaries.
Basel, June 25, 2020 - Novartis has reached settlements with the US Department of Justice (DOJ) and the US Securities and Exchange Commission (SEC) resolving all Foreign Corrupt Practices Act (FCPA) investigations into historical conduct by the Company and its subsidiaries.
EPFL scientists have coupled a new material with light at the level of a single photon. The achievement opens up prospects for better controlling and understanding the properties of quantum-correlated systems, where theoretical calculations are difficult.
Despite the coronavirus lockdown, the renovation and extension of Früebüel research station in Walchwil (Canton of Zug) was completed nearly on schedule.
Anyone who owns a smartphone, uses social media or drives a "smart" car unwittingly reveals a lot about themselves.
Students from EPFL's EAST laboratory have installed recycled lights and restrooms at the Bex & Arts sculpture triennial - set to run from 22 June to 18 October - and repurposed parts of a disused tram depot in Bern.
The circular economy is gaining a foothold in more and more areas: Some have already established business models, in others it is only visible in visionary pioneering projects.
News in Brief
Health - 08:01
Novartis Kisqali receives the highest rating of any CDK4/6 inhibitor on the ESMO Magnitude of Clinical Benefit Scale
Novartis Kisqali receives the highest rating of any CDK4/6 inhibitor on the ESMO Magnitude of Clinical Benefit Scale
Pharmacology - Sep 19
Novartis reports late-breaking data from Phase III COMBI-i trial of spartalizumab (PDR001) with Tafinlar and Mekinist in advanced melanoma
Novartis reports late-breaking data from Phase III COMBI-i trial of spartalizumab (PDR001) with Tafinlar and Mekinist in advanced melanoma